盐酸利多卡因一水合物

Name: 盐酸利多卡因一水合物
Brand: 济南圣和化工有限公司

CAS 6108-05-0C14H23ClN2OMW 270.80

本页收录盐酸利多卡因一水合物，CAS 登记号为 6108-05-0，分子式 C14H23ClN2O，分子量 270.80，归类于有机化学品。作为主营产品之一，济南圣和化工有限公司可提供从公斤级到吨级的稳定供货，随货附 COA 与质检资料。

产品概览

CAS号	6108-05-0
分子式	C14H23ClN2O
分子量	270.80
纯度	按批次COA提供(不公开发布)
包装	按订单/批次确认(不公开发布)
应用领域	有机化学品
类别	有机化学品

应用领域

有机化学品

盐酸利多卡因一水合物在有机化学品领域使用广泛。采购前请确认纯度等级与包装形式，以批次 COA 为验收依据。

包装与储存

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

运输常规化工运输

样品可协商提供

交期现货/按订单安排

供货能力：盐酸利多卡因一水合物备有现货，包装形式为按订单/批次确认(不公开发布)。我们支持对公转账并开具增值税发票，山东省内可安排快速配送，省外按物流时效发货，具体请联系 info@591daili.com。

质量与文件

每批产品随货提供 COA（分析证书）；可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

作为化工原料供应服务商，济南圣和化工有限公司长期服务于化工贸易、食品添加、医药中间体、日化原料等行业的采购需求。除盐酸利多卡因一水合物外，您还可以在站内按 CAS 号或产品分类检索更多品类，获取规格与报价。

常见问题

盐酸利多卡因一水合物的 CAS 号是多少？

盐酸利多卡因一水合物的 CAS 号为 6108-05-0。

该产品的纯度和包装规格是什么？

常规纯度规格为按批次COA提供(不公开发布)，包装为按订单/批次确认(不公开发布)，随货提供 COA。

盐酸利多卡因一水合物有什么用途？

主要应用于有机化学品。

如何购买或获取报价？

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系，注明产品名称、CAS 号与需求数量，一个工作日内回复报价。供应商：济南圣和化工有限公司。

PubChem 公开数据

Description

Lidocaine hydrochloride monohydrate · CAS 6108-05-0 · C14H23ClN2O. UNII EC2CNF7XFP.

Identification

CAS Registry Number	6108-05-0
PubChem CID	6314
Molecular formula	C14H23ClN2O
IUPAC name	2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide;hydrochloride
UNII (FDA)	EC2CNF7XFP

Computed Descriptors

Molecular Weight	270.80
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	5
Exact Mass	270.1498911
Monoisotopic Mass	270.1498911
Topological Polar Surface Area	32.3
Heavy Atom Count	18
Formal Charge	0
Complexity	228

Physical description & handling notes

155.4 Å² [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

GHS Hazard Classification

Reported hazard statements	H301 (82.5%), H302 (17.5%), H315 (40.3%), H319 (40.3%), H334 (37.3%), H335 (40.3%), H412 (37.3%)

H301 (82.5%): Toxic if swallowed [Danger Acute toxicity, oral]

H302 (17.5%): Harmful if swallowed [Warning Acute toxicity, oral]

Documented Uses

For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.
Information on 1 consumer products that contain Lidocaine hydrochloride in the following categories is provided:
Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, hydrochloride (1:1): ACTIVE
Breast Feeding; Lactation; Milk, Human; Antiarrhythmics; Local Anesthetics
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS.

Synonyms

Lidocaine hydrochloride; 73-78-9; LIDOCAINE HCL; Lidothesin; Lignocaine hydrochloride; Laryng-O-jet; Anestacon; Lidocaton; Glydo; Xylocaine Viscous; LIDOCAINE VISCOUS; LTA II KIT; PEDIATRIC LTA KIT; LARYNG-O-JET KIT; Lidocaine hydrochloride anhydrous; LIDOPEN

Frequently Asked Questions

What are the CAS number and molecular formula of Lidocaine hydrochloride monohydrate?

CAS 6108-05-0; molecular formula C14H23ClN2O; molecular weight — g/mol.

What other names is Lidocaine hydrochloride monohydrate known by?

Lidocaine hydrochloride, 73-78-9, LIDOCAINE HCL, Lidothesin, Lignocaine hydrochloride, Laryng-O-jet.

Is Lidocaine hydrochloride monohydrate classified as hazardous?

Hazard statements reported: H301, H302, H315, H319, H334.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.